1.
Platelets
; 33(4): 652-653, 2022 May 19.
Article
in English
| MEDLINE | ID: covidwho-1713377
ABSTRACT
In 2021, the world experienced the most extensive vaccination campaign to defeat COVID-19. Many cases of idiopathic thrombocytopenia have been reported following injections of SARS-Cov-2 mRNA vaccine. We present the case of a 73-year-old woman with de novo ITP after a first injection of SARS-Cov-2 mRNA vaccine (Moderna vaccine) who experienced a successful rechallenge of SARS-Cov-2 mRNA vaccine (Pfizer vaccine) a few months later.
Subject(s)
COVID-19 , Purpura, Thrombocytopenic, Idiopathic , Vaccines , Aged , COVID-19 Vaccines/adverse effects , Female , Humans , Purpura, Thrombocytopenic, Idiopathic/etiology , RNA, Messenger , SARS-CoV-2 , Vaccines, Synthetic , mRNA Vaccines
2.
Haematologica
; 107(6): 1454-1459, 2022 06 01.
Article
in English
| MEDLINE | ID: covidwho-1523669
Subject(s)
COVID-19 , Leukemia, Lymphocytic, Chronic, B-Cell , Lymphoma , Antigens, CD20/genetics , Humans , Immunoglobulins , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Lymphoma/drug therapy , RNA, Messenger , Rituximab/therapeutic use
3.
Intern Emerg Med
; 16(5): 1411-1414, 2021 08.
Article
in English
| MEDLINE | ID: covidwho-1002166